Teva Wins $100M Settlement From Broker Over ARS
Generic drugmaker Teva Pharmaceutical Industries Ltd. has reached a $100 million settlement with an unnamed institution that served as a broker for the company and put its investments in auction rate...To view the full article, register now.
Already a subscriber? Click here to view full article